LAI GOLDMAN MYLA 4
4 · Akoya Biosciences, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
LAI GOLDMAN MYLA
Director
Transactions
- Award
Stock Option (Right to Buy
2022-06-01+30,549→ 30,549 totalExercise: $11.24Exp: 2032-06-01→ Common Stock (30,549 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2023, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant.